NBY / NovaBay Pharmaceuticals, Inc. - Kepemilikan Institusional - Pembeli

NovaBay Pharmaceuticals, Inc.
US ˙ NYSEAM

Kepemilikan Institusional dan Dana - Pembeli

Pemegang saham utama yang telah membuka posisi baru di NovaBay Pharmaceuticals, Inc. meliputi Rangeley Capital, LLC, dan StoneX Group Inc. .

Halaman ini menunjukkan perubahan dalam struktur kepemilikan dengan mencantumkan lembaga, dana, dan pemegang saham utama yang telah meningkatkan kepemilikan mereka atau membuka posisi baru pada periode pelaporan terakhir. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium.

Tanggal File Sumber Investor Ketik Presyo ng Avg
(Silangan)
Saham Δ Saham
(%)
Dilaporkan
Nilai
($1000)
Nilai Δ
(%)
Alokasi Port
(%)
2025-08-12 13F XTX Topco Ltd 20,310 2.33 12 0.00
2025-08-14 13F Two Sigma Securities, Llc 24,280 38.96 14 40.00
2025-07-17 13F C2C Wealth Management, LLC 98,000 78.18 57 75.00
2025-08-14 13F UBS Group AG 3,385 351.94 2
2025-08-12 13F Proequities, Inc. 0 0
2025-08-14 13F Bank Of America Corp /de/ 55 27.91 0
2025-07-24 NP FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 27,647 10.41 15 0.00
2025-08-14 13F Rangeley Capital, LLC 33,210 19
2025-08-13 13F/A StoneX Group Inc. 14,877 4
Other Listings
DE:B9P0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista